Palantir NHS pilot adds GP data beyond hospital platform
Palantir’s NHS data platform has quietly added GP data in a pilot, expanding the software beyond its existing hospital use. The move broadens PLTR’s public-sector footprint but also deepens scrutiny around privacy, consent and the company’s controversial role in UK healthcare.
STOCK PHOTO · PHIL EVENDENThe story
GP data has been added to Palantir's NHS data platform through a pilot. This represents a significant expansion beyond the software's current use in hospitals. Palantir's NHS role has already drawn controversy because its software is used to connect and analyze healthcare information across services. Adding general-practice data extends the platform into a more sensitive and broader source of patient information, changing the scope of the deployment.
For Palantir, the direct mechanism is public-sector software adoption: a wider NHS deployment could create additional usage and reference value for its government business. For the NHS, the mechanism is operational access to data held outside hospitals, while for patients and privacy advocates the relevant issue is how access, governance and consent are handled.
The next evidence should be the pilot's participating organizations, governance terms and any decision on expansion. Palantir's next reported results will also show whether government growth is translating into revenue.
Our read · Sun, Sep 13
Palantir’s NHS data platform added GP data in a pilot, extending PLTR’s software beyond hospital use.
Why. The strategic value is broader NHS penetration: GP data gives Palantir a larger potential healthcare deployment and a public-sector reference point, while the company’s $4.5B FY2025 revenue and 56.2% year-over-year growth show an established commercial base. The missing contract value, rollout timetable and governance terms prevent this pilot from supporting a dated directional call on the shares.
Both cases
What could change this view: The pilot could stall or face political and privacy-related resistance before expanding beyond its current scope.
Who reported it · 1
Keep reading
More on PLTR
Palantir’s U.S. commercial revenue overtakes government in Q3Palantir and Nvidia reportedly curb AI model use over data fearsStock Market Today, Aug. 7: Palantir Surges on Bank of America Upbeat View After Strong EarningsPalantir partners with Nvidia to integrate secure AI solutions for enterprise clientsPalantir upgraded by analyst for AI orchestration roleLatest on the Wire
Anthropic debut fails to halt technology-led slide in US stocksUS MATCH Act puts ASML at center of China chip export disputeBeijing plans to bar young red-chip firms from overseas listingsGerman producer prices jump 8.1% in October as industrial inflation acceleratesChina seeks protections to restart US private-equity investmentsContinue on the Wire →Latest on the Wire
Walmart raises full-year outlook as e-commerce wins shoppersAnthropic IPO could become the largest in US history on ThursdayContinuing claims rise as Goldman sees Fed hikes in December and MarchPIF Tower in Riyadh reportedly damaged in second Houthi attackContinue on the Wire →Top this week
Nvidia allies lobby board to bring back Jensen Huang as CEONvidia chair rules out Huang return as CEO after 75% sales outlookAnthropic Said to Guide IPO Pricing Above Market RangeNvidia interim CEO Colette Kress faces first earnings test after HuangBitcoin nears $64,000 as Anthropic IPO lifts Nasdaq futures nearly 2%About this report
Reported by Financial Times as GP data quietly added to Palantir’s NHS data platform
, . Who answers for this
The only report in this record. Closes are licensed end-of-day data from Databento; the move after a story is its first close against the close before it. How this is decided →
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →